05/31/2024
6:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
4:25 PM | Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:55 PM | Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
10:15 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:50 PM | Ionis Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024
3:52 PM | Ionis Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024
3:53 PM | Ionis Pharmaceuticals (Filer)
| Form ARS | |
|
04/17/2024
4:16 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
4:19 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
7:59 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/16/2024
7:50 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/08/2024
5:04 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:52 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
4:52 PM | Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:13 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
8:10 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:38 PM | Ionis Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2024
10:17 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
9:39 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
02/16/2024
6:47 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:34 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
5:09 AM | BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
6:54 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:54 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:54 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
6:55 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:31 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:34 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:21 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:23 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:25 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:28 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:30 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The Only Energy Play You Should Be Looking At (Ad) Open AI’s Sam Altman recently helped this company raise $577 million in funding…
What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. |
02/02/2024
4:19 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
9:27 AM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144/A | |
02/01/2024
9:12 AM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144/A | |
01/31/2024
8:30 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
4:34 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:34 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
6:10 AM | Ionis Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
4:55 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:59 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:07 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:44 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:44 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:47 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:48 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:48 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:48 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
4:49 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
8:44 PM | Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:46 PM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:49 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:34 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:40 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:22 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:26 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:29 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:31 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
8:32 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2024
7:49 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:49 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:49 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:49 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:49 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:50 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:50 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:50 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:50 PM | Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:50 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
7:51 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/12/2024
2:58 PM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
4:22 PM | Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:23 PM | BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:23 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:23 PM | Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:23 PM | Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:23 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:23 PM | Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:23 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:24 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:24 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
4:54 PM | Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
SHOCKING Crypto Leak… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
01/02/2024
4:54 PM | HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
4:54 PM | Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
6:18 PM | Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
6:18 PM | Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
6:18 PM | Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:22 PM | Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
10:27 AM | Ionis Pharmaceuticals (Subject)
PARSHALL B LYNNE (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
10:33 AM | Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023
10:15 AM | Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
